FDA Form 1572 is a required document in which a clinical investigator commits to conducting an IND study in accordance with FDA regulations and the approved protocol.
It documents investigator qualifications, site information, and the investigatorís responsibilities for informed consent, safety reporting, and data integrity. Sponsors rely on the 1572 to establish accountability and confirm the study team meets regulatory expectations. The form is routinely reviewed during audits and FDA inspections as evidence of investigator oversight commitments. Keeping forms accurate and current supports inspection readiness and compliant study conduct.